RENAISSANCE TECHNOLOGIES LLC

Holdings History for Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)

Symbol: STRO on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-1,424,797	-100%	$11.57	Q4 2025
30 Sep 2025	0%	+0%	$1,237,294	1,424,797	+511,600	+56%	$0.87	Q3 2025
30 Jun 2025	0%	+0%	$651,931	913,197	+44,200	+5.1%	$0.71	Q2 2025
31 Mar 2025	0%	-0%	$565,369	868,997	-146,214		$0.65	Q1 2025
31 Dec 2024	0%	+0%	$1,867,988	1,015,211	+187,114	+23%	$1.84	Q4 2024
30 Sep 2024	0%	+0%	$2,865,216	828,097	+108,600	+15%	$3.46	Q3 2024
30 Jun 2024	0%	+0%	$2,108,126	719,497	+233,700	+48%	$2.93	Q2 2024
31 Mar 2024	0%	-0%	$2,745,000	485,797	-170,000	-26%	$5.65	Q1 2024
31 Dec 2023	0%	+0%	$2,813,000	655,797	+352,900	+117%	$4.29	Q4 2023
30 Sep 2023	0%	+0%	$1,051,000	302,897	+33,400	+12%	$3.47	Q3 2023
30 Jun 2023	0%	+0%	$1,253,000	269,497	+140,100	+108%	$4.65	Q2 2023
31 Mar 2023	0%	+0%	$598,000	129,397	+99,497	+333%	$4.62	Q1 2023
31 Dec 2022	0%	-0%	$242,000	29,900	-186,000	-86%	$8.09	Q4 2022
30 Sep 2022	0%	+0%	$1,198,000	215,900	+68,200	+46%	$5.55	Q3 2022
30 Jun 2022	0%	+0%	$770,000	147,700	+147,700	NEW	$5.21	Q2 2022
31 Mar 2022		-0%	$0	0	-48,700	-100%	$11.57	Q1 2022
31 Dec 2021	0%	+0%	$725,000	48,700	+48,700	NEW	$14.89	Q4 2021
31 Mar 2021		-0%	$0	0	-30,014	-100%	$11.57	Q1 2021
31 Dec 2020	0%	+0%	$652,000	30,014	+30,014	NEW	$21.72	Q4 2020
30 Sep 2020		-0%	$0	0	-149,513	-100%	$11.57	Q3 2020
30 Jun 2020	0%	+0%	$1,160,000	149,513	+149,513	NEW	$7.76	Q2 2020
31 Mar 2020		-0%	$0	0	-10,300	-100%	$11.57	Q1 2020
31 Dec 2019	0%	+0%	$113,000	10,300	+10,300	NEW	$10.97	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.